초록접수 현황
| 17F-056 | 구연 미채택시 포럼 발표 |
Surgery for Hemoptysis in Patients with Benign Lung Disease
Ju Sik Yun¹, Sang Yun Song¹, Gwan Sic Kim², Kyo Seon Lee², Do Wan Kim², Yochun Jung², In Seok Jeong², Bong-Suk Oh², Byoung Hee Ahn², Seok Kim, Kook Joo Na¹
¹Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hwasun Hospital, Chonnam National University College of Medicine, Jeollanam-do, Republic of Korea., ²Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Chonnam National University College of Medicine, Gwangju, Republic of Korea
Purpose : Hemoptysis can be life threatening condition that requires urgent treatment. Surgery still plays an important role in managing this critical situation, although previous reports have shown the high postoperative morbidity and mortality rate.
Methods : We reviewed the retrospectively collected data from 94 patients undergoing pulmonary resection for various benign lung disease with hemoptysis from 2010 to 2016. Baseline characteristics, surgical factors, postoperative outcomes were analyzed.
Results : The ratio of male to female was 1:1; with mean age of 58.2 ± 11.1 years. The etiology of hemoptysis included aspergilloma in 58 patients, bronchiectasis in 10, tuberculosis in 7, necrotizing bronchiolitis in 6 and other inflammatory disease in 13. A total of 21 patients (22.3%) underwent an emergency operation and 73 had a elective operation. Pulmonary resection was performed by thoracotomy (n=53, 56.4%) and VATS (n=41). Sublobar resection (n=50, 53.2%) were performed more often than lobectomy (n=35). Pneumonectomy was performed in 7 patients and bilobectomy in 2. The postoperative morbidity occurred in 23 patients (24.5%). And in-hospital mortality was 3.2% (n=3). Complications were less frequent in patients with elective operation, VATS, sublobar resection groups than each control groups. Multivariate analysis showed that the patients with VATS had a decreased risk of developing postoperative complications (OR, 12.8, 95% CI, 1.29-127.9; p=0.03).
Conclusion : Surgical resection for hemoptysis in patients with benign lung diseases is the mainstay of effective treatment with acceptable morbidity and mortality rate. If applicable, we recommend elective (planned) sublobar resection through VATS in order to improve the postoperative outcomes.
Methods : We reviewed the retrospectively collected data from 94 patients undergoing pulmonary resection for various benign lung disease with hemoptysis from 2010 to 2016. Baseline characteristics, surgical factors, postoperative outcomes were analyzed.
Results : The ratio of male to female was 1:1; with mean age of 58.2 ± 11.1 years. The etiology of hemoptysis included aspergilloma in 58 patients, bronchiectasis in 10, tuberculosis in 7, necrotizing bronchiolitis in 6 and other inflammatory disease in 13. A total of 21 patients (22.3%) underwent an emergency operation and 73 had a elective operation. Pulmonary resection was performed by thoracotomy (n=53, 56.4%) and VATS (n=41). Sublobar resection (n=50, 53.2%) were performed more often than lobectomy (n=35). Pneumonectomy was performed in 7 patients and bilobectomy in 2. The postoperative morbidity occurred in 23 patients (24.5%). And in-hospital mortality was 3.2% (n=3). Complications were less frequent in patients with elective operation, VATS, sublobar resection groups than each control groups. Multivariate analysis showed that the patients with VATS had a decreased risk of developing postoperative complications (OR, 12.8, 95% CI, 1.29-127.9; p=0.03).
Conclusion : Surgical resection for hemoptysis in patients with benign lung diseases is the mainstay of effective treatment with acceptable morbidity and mortality rate. If applicable, we recommend elective (planned) sublobar resection through VATS in order to improve the postoperative outcomes.
책임저자: Sang Yun Song
Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hwasun Hospital, Chonnam National University College of Medicine, Jeollanam-do, Republic of Korea
발표자: Ju Sik Yun, E-mail : jusikyun@gmail.com